| |
|
|
|
ADMA Biologics- Inc.  
|
|
4.79 0.18 (0.04%) |
07-19 15:25 |
|
Open: |
4.6 |
Pre close: |
4.61 |
Target:
|
6.32 
|
|
High: |
4.82 |
Low: |
4.6 |
Resistance:
|
5.41
6.32
|
|
Volume: |
69,020 |
Market Cap: |
216M |
Support:
|
4.64
4.17
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.70
|
MACD |
MACD(12,26):
|
-0.05 |
|
MA(20): |
4.60  |
Signal(12,26,9): |
-0.10 |
|
MA(100): |
4.81 |
Stochastic Oscillator |
%K(14,3):
|
57.91 |
|
MA(250): |
3.83 |
%D(3): |
54.10 |
|
Average Volume(K) |
3-Month: |
24555
|
52-Week |
High:
|
5.70 |
|
10-Days: |
20126 |
Low: |
2.01 |
|
RSI |
RSI(14):
|
53.35 |
Change(%): |
34.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.550 |
Return on Equity (ttm) |
-897.4 |
Shares Out. (M) |
46.35 |
|
EPS Est. Current Year |
-1.740 |
Return on Assets (ttm) |
-101.3 |
Shares Float (M) |
46.20 |
|
EPS Est. Next Year |
-1.080 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.30 |
|
EPS Est. Next Quarter |
-0.370 |
Qtrly Rev. Growth |
53.8 |
% Held by Institutions |
88.80 |
|
Forward EPS |
-0.390 |
Gross Profit (p.s.) |
-0.162 |
Shares Short (K) |
1522 |
|
Book Value (p.s.) |
9.120 |
EBITDA (p.s.) |
-0.468 |
P/E |
-8.71 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.53 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-48.31 |
P/S |
276898816.00 |
|
Operating Margin |
-183.09 |
Levered Free Cash Flow
(M) |
-38.12 |
P/CF |
-4.60 |
|
|
|
|
|
|
